There were 1,715 press releases posted in the last 24 hours and 442,244 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Immunomedics Announces Antitumor Effect of Sacituzumab Govitecan (IMMU-132) in Triple-Negative Breast Cancer Can be Enhanced With DNA-Repair Inhibitors

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image